Real-world experience with brodalumab in a Portuguese cohort of patients with moderate-to-severe psoriasis
This real-world data show that brodalumab is effective and safe for the treatment of moderate-to- severe psoriasis.
Authors
- Maria João Cruz
- Paulo José Gonçalves Ferreira (ORCID: https://orcid.org/0000-0001-5042-4213)
- Tiago Torres (ORCID: https://orcid.org/0000-0003-0404-0870)
- Pedro Mendes‐Bastos (ORCID: https://orcid.org/0000-0002-2439-920X)
- Joana Antunes (ORCID: https://orcid.org/0000-0003-0221-7193)
- Fernando Mota (ORCID: https://orcid.org/0000-0003-3385-2552)
Institutions
- Universidade do Porto (PT)
- Hospital de São João (PT)
- Unidade Local de Saúde de São José (PT)
- Hospital da Senhora da Oliveira Guimarães (PT)
- Centro Hospitalar Lisboa Norte (PT)
- Hospital de Santo António (PT)
- Hospital de Santa Maria (PT)
- Hospital de Clínicas (UY)
- Hospital do Desterro (PT)
Publication Details
- Journal
- Drugs in Context
- Published
- 2025-03-11
- DOI
- https://doi.org/10.7573/dic.2024-11-4
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00